background
disput
whether
recurr
episod
wheez
preschoolag
children
compris
distinct
asthma
phenotyp
object
sought
prospect
assess
airflow
limit
airway
inflamm
children
year
old
episod
virusinduc
wheez
method
ninetythre
children
year
old
histori
mild
virusinduc
episod
wheez
abl
perform
accept
fraction
exhal
nitric
oxid
feno
maneuv
spirometri
forc
expiratori
time
second
follow
prospect
lung
function
feno
valu
measur
everi
week
baselin
within
first
hour
acut
wheez
episod
day
day
later
symptom
score
peak
flow
measur
record
daili
result
fortythre
children
experienc
wheez
episod
day
feno
valu
significantli
increas
wherea
forc
expiratori
volum
second
fev
significantli
decreas
compar
baselin
ppb
interquartil
rang
iqr
ppb
vs
ppb
iqr
ppb
l
iqr
l
vs
l
iqr
l
respect
p
airflow
limit
day
revers
bronchodil
fev
feno
valu
significantli
associ
lower
upper
respiratori
tract
symptom
assess
longitudin
crosssect
time
point
independ
atopi
feno
fev
valu
return
baselin
level
within
day
conclus
mild
episod
wheez
preschool
character
enhanc
airway
inflamm
revers
airflow
limit
asthmarel
symptom
feno
valu
increas
significantli
first
hour
return
person
baselin
within
day
initi
episod
longitudin
followup
suggest
symptom
inflamm
lung
function
correl
well
phenotyp
asthma
j
allergi
clin
immunol
signific
proport
preschoolag
children
experi
recurr
episod
wheez
cough
short
breath
mainli
associ
viral
respiratori
tract
infect
asthma
defin
complex
disord
character
specif
symptom
sign
revers
airway
obstruct
bronchial
hyperrespons
airway
inflamm
pauciti
relev
evid
preschool
age
group
might
explain
term
asthma
frequent
avoid
altern
approach
suggest
airway
inflamm
wheez
infant
young
children
comprehens
studi
mainli
ethic
limit
although
evid
airway
remodel
quit
earli
life
fraction
exhal
nitric
oxid
feno
receiv
consider
attent
noninvas
marker
assess
airway
inflamm
diagnos
asthma
preschool
subdivid
wheezer
variou
phenotyp
major
similar
studi
crosssect
design
howev
well
establish
feno
valu
influenc
current
recent
viral
infect
use
oral
inhal
steroid
although
challeng
spirometri
feasibl
preschool
children
take
account
physiolog
lung
function
age
group
dynam
forc
expiratori
trial
fact
maxim
expiratori
flowvolum
mefv
maneuv
effort
depend
standard
criteria
accept
repeat
mefv
recommend
howev
adequ
studi
whether
preschoolag
child
perform
accept
mefv
trial
wheez
episod
extent
paramet
fluctuat
episod
well
extent
util
moreov
toddler
older
children
asthmarel
symptom
attempt
correl
inflamm
lung
function
symptom
frequent
inconclus
neg
nevertheless
paramet
assess
longitudin
parallel
studi
aim
longitudin
evalu
associ
airway
inflamm
airflow
limit
symptom
cours
episod
virusinduc
wheez
disord
steroidna
children
year
age
children
year
age
outpati
clinic
institut
given
previou
diagnosi
episod
viral
wheez
accord
european
respiratori
societi
task
forc
virusinduc
asthma
accord
practic
allergi
practal
consensu
report
invit
particip
patient
elig
given
diagnosi
minimum
year
least
mild
wheez
episod
preced
month
without
previou
need
hospit
admiss
accord
medic
record
need
inhal
bagonist
inhal
corticosteroid
montelukast
patient
receiv
inhal
corticosteroid
montelukast
regular
episod
basi
recruit
least
washout
period
furthermor
children
requir
abl
perform
mefv
effort
forc
expiratori
time
fet
second
greater
correct
onlin
feno
maneuv
accord
standard
criteria
studi
approv
institut
ethic
committe
written
inform
consent
obtain
parent
symptom
medic
daili
peak
expiratori
flow
measur
symptom
score
modifi
johnston
et
al
medic
use
peak
expiratori
flow
pef
measur
record
daili
parent
diari
card
throughout
studi
upper
airway
symptom
diari
card
includ
blockedstuffi
nose
runni
nose
sneezingitchi
nose
itchysorewateri
eye
hoars
voic
sore
throat
lower
airway
symptom
includ
cough
day
night
wheezingnoisi
breath
day
night
cough
wheezingnoisi
breath
exercis
symptom
score
symptom
sever
troublesom
symptom
parent
advis
contact
studi
physician
arrang
appoint
within
hour
child
start
wheez
least
lower
airway
symptom
difficulti
breath
nighttim
awaken
pef
measur
daili
morn
even
use
electron
pef
meter
nspire
health
longmont
colo
record
time
date
along
pef
measur
record
use
indirect
way
assess
complianc
fill
diari
card
detail
see
method
section
articl
onlin
repositori
wwwjacionlineorg
allerg
sensit
level
serumspecif
ige
immunocap
phadia
uppsala
sweden
panel
local
relev
common
aeroallergen
food
allergen
measur
either
wheez
episod
age
year
children
without
wheez
episod
studi
patient
classifi
atop
least
allergenspecif
ige
greater
iuml
detail
see
method
section
articl
onlin
repositori
feno
measur
airway
inflamm
determin
base
feno
valu
part
per
billion
use
niox
mino
aerocrin
solna
sweden
chemiluminesc
analyz
standard
mode
exhal
time
attempt
per
visit
accord
current
guidelin
detail
see
method
section
articl
onlin
repositori
spirometri
spirometri
perform
jaeger
masterscopepc
spiromet
viasi
healthcar
ochberg
germani
maneuv
perform
children
stand
posit
use
nose
clip
incent
anim
result
report
least
technic
accept
curv
maneuv
per
visit
determin
accord
standard
criteria
fet
greater
second
obtain
forc
expiratori
volum
second
fev
forc
vital
capac
fet
backextrapol
volum
vbe
best
maneuv
highest
sum
fev
forc
vital
capac
valu
record
spirometri
perform
bronchodil
mg
salbutamol
aerolin
glaxosmithklin
athen
greec
deliv
metereddos
inhal
spacer
aerochamb
plu
flow
vu
trudel
medic
intern
london
ontario
canada
viral
identif
nasal
wash
perform
ml
normal
salin
nostril
virus
identifi
mean
pcr
previous
describ
detail
see
method
section
articl
onlin
repositori
recruit
baselin
questionnair
includ
demograph
characterist
data
respect
wheez
episod
obtain
children
follow
evalu
diari
card
new
feno
spirometr
measur
regularli
everi
week
wheez
episod
reach
sixth
birthday
measur
repeat
first
hour
begin
episod
day
day
day
day
later
nasal
wash
specimen
obtain
day
episod
children
receiv
mg
salbutamol
time
daili
sampl
size
least
subject
would
suffici
detect
pair
feno
measur
differ
least
accuraci
niox
mino
take
account
refer
precis
accuraci
ppb
measur
valu
ppb
precis
ppb
measur
valu
ppb
least
power
signific
level
atop
statu
may
influenc
feno
valu
pair
measur
assess
atop
nonatop
wheezer
preval
sensit
preschoolag
children
aforement
inclus
characterist
expect
approxim
thu
least
wheezer
enough
least
subject
per
group
approxim
children
wheez
first
year
life
expect
ceas
wheez
age
year
adjust
number
recruit
children
accordingli
take
account
addit
failur
perform
requir
test
loss
followup
number
children
need
recruit
calcul
descript
statist
present
median
interquartil
rang
iqr
nonnorm
distribut
continu
variabl
mean
sd
normal
distribut
variabl
wilcoxon
rank
sum
student
test
use
compar
binari
outcom
atopi
viru
identif
sex
time
point
wilcoxon
matchedpair
rank
sum
student
pair
test
use
betweentimepoint
comparison
variabl
associ
categor
data
assess
use
pearson
x
test
analys
across
time
point
perform
gener
estim
equat
adjust
known
confound
height
age
atopi
model
feno
valu
logtransform
follow
normal
distribut
day
day
period
variabl
treat
time
depend
except
age
sex
atopi
height
detail
see
method
section
articl
onlin
repositori
candid
consecut
examin
children
recruit
unabl
perform
correct
feno
maneuv
unabl
perform
spirometri
fet
greater
second
mean
age
recruit
year
time
point
signific
differ
age
sex
height
baselin
measur
atop
children
nonatop
children
children
complet
studi
without
wheez
episod
regular
followup
visit
occur
everi
day
fortythre
children
least
wheez
episod
year
recruit
episod
equal
distribut
among
season
except
summer
wherea
avail
baselin
measur
differ
season
significantli
differ
assess
individu
manner
data
shown
baselin
characterist
similar
atop
nonatop
children
tabl
initi
assess
begin
episod
day
children
reevalu
day
day
day
day
later
complianc
high
electron
pef
record
regular
daili
measur
wheez
episod
respect
assess
indirectli
none
children
report
wheez
unrel
appar
upper
respiratori
tract
infect
lower
respiratori
symptom
four
children
atop
episod
shortlast
selflimit
mild
upper
respiratori
tract
symptom
without
lower
respiratori
tract
symptom
wheez
vast
major
children
achiev
correct
feno
maneuv
proper
train
baselin
measur
within
expect
normal
rang
tabl
articl
onlin
repositori
wwwjacionlin
org
feno
pair
chang
baselin
present
fig
fet
wheez
episod
affect
children
abil
perform
reliabl
reproduc
mefv
measur
fet
second
set
mefv
trial
bronchodil
significantli
lower
fet
bronchodil
tabl
ii
effort
fet
greater
second
comparison
prebronchodil
fet
postbronchodil
fet
fet
base
wilcoxon
matchedpair
rank
sum
test
time
point
fev
valu
compar
atop
nonatop
wheezer
see
tabl
articl
onlin
repositori
wwwjacionlineorg
bronchodil
respons
significantli
higher
baselin
valu
day
iqr
vs
baselin
nasal
wash
sampl
day
avail
children
least
viru
identifi
children
rhinoviru
preval
identifi
sampl
follow
adenoviru
sampl
parainfluenza
sampl
coronaviru
sampl
influenza
sampl
coinfect
rhinoviru
adenoviru
note
case
parainfluenza
viru
case
coronaviru
anoth
case
differ
viru
identif
regard
atop
statu
observ
p
feno
fev
valu
differ
significantli
virusposit
virusneg
case
data
shown
pairwis
crosssect
correl
day
feno
valu
prebronchodil
fev
valu
symptom
weak
nonsignific
see
fig
articl
onlin
repositori
wwwjacionlineorg
howev
assess
longitudin
day
day
prebronchodil
fev
feno
valu
significantli
associ
symptom
fig
tabl
iii
iv
shown
studi
acut
episod
viral
wheez
virusinduc
asthma
children
year
age
character
airway
inflamm
defin
mean
increas
feno
valu
airflow
limit
decreas
fev
valu
bronchodil
revers
well
symptom
noisi
breath
cough
short
breath
sign
wheez
tachypnea
need
respons
inhal
b
agonist
evid
airway
bronchial
hyperrespons
indic
cough
exercis
evid
entiti
share
core
characterist
asthma
phenotyp
independ
atop
statu
interestingli
crosssect
correl
feno
prebronchodil
fev
symptom
nonsignific
similar
studi
older
children
significantli
associ
assess
longitudin
fact
crosssect
associ
signific
contrast
longitudin
evalu
studi
highlight
need
prospect
assess
timedepend
paramet
furthermor
feno
fev
fluctuat
least
age
group
children
individu
diagnost
valu
help
monitor
episod
knowledg
first
studi
follow
natur
histori
virusinduc
asthmat
episod
demonstr
inflamm
lung
function
symptom
significantli
correl
assess
parallel
moreov
feno
measur
spirometri
demonstr
feasibl
wheez
episod
studi
shown
increas
bronchial
epitheli
induc
nitric
oxid
synthas
ino
express
vivo
infect
rhinoviru
vitro
infect
influenza
respiratori
syncyti
viru
moreov
epitheli
ino
express
repres
major
determin
feno
valu
wherea
ino
activ
account
measur
feno
valu
addit
small
proport
feno
origin
oropharynx
oral
caviti
collect
take
consider
exist
nonenzymat
format
nitric
oxid
nitrit
saliva
observ
synthasemedi
format
least
magnitud
format
nitrit
fact
examin
children
cohort
refrain
nitraterich
food
measur
contribut
oropharyng
exhal
measur
feno
valu
expect
less
proport
correspond
less
ppb
feno
measur
time
point
suggest
neglig
contribut
oropharyng
mucos
measur
well
establish
feno
valu
increas
experiment
rhinoviru
influenza
viru
presum
upper
respiratori
tract
infect
asthmat
nonasthmat
subject
case
nasal
subject
diseas
limit
upper
respiratori
tract
suggest
product
mainli
associ
lower
respiratori
tract
patholog
moreov
shown
rhinoviru
abl
infect
bronchial
epithelium
induc
local
inflamm
probabl
lead
asthma
exacerb
predispos
subject
airway
consid
play
pivot
role
antivir
defens
feno
chang
measur
episod
conceiv
reflect
hostdefens
respons
virusinduc
airway
inflamm
feno
measur
studi
return
baselin
valu
within
day
probabl
reflect
basal
product
rather
diseas
activ
previous
suggest
persist
popul
clear
whether
virusinduc
feno
increas
downregul
corticosteroid
seem
unlik
steroid
especi
rhinoviru
infect
seem
modul
virusinduc
interferon
respons
bronchial
epithelium
might
explain
least
phenotyp
age
group
feno
seem
perform
well
predict
inhal
corticosteroid
respons
corticosteroid
therapi
seem
diseasemodifi
effect
progress
episod
wheez
howev
known
whether
acut
shortlast
inflammatori
respons
especi
relaps
multipl
time
new
respiratori
tract
viral
infect
could
predispos
explain
transit
unclear
uncertain
asthmat
statu
definit
chronic
inflammatori
process
character
asthma
studi
need
elucid
issu
promis
approach
alreadi
initi
wwwpredictaeu
children
fet
greater
second
young
children
rel
larg
airway
size
compar
absolut
lung
volum
empti
result
fastest
rate
empti
therefor
explain
shorter
durat
forc
expir
spirometr
maneuv
measur
affect
episod
respect
qualiti
durat
effort
comparison
consecut
prebronchodil
forc
expiratori
effort
base
fet
differ
time
point
significantli
differ
interestingli
wait
bronchodil
respons
perform
second
mefv
trial
appear
shorten
fet
durat
might
effect
bronchodil
per
se
might
effort
relat
almost
half
examin
children
time
point
measur
achiev
fet
second
prebronchodil
postbronchodil
spirometr
effort
respect
spirometri
fev
valu
indic
bronchial
obstruct
decreas
significantli
wheez
episod
spontan
return
baselin
within
day
therefor
abnorm
pulmonari
function
present
episod
shown
previous
moreov
mean
bronchodil
respons
significantli
higher
begin
episod
comparison
baselin
valu
statist
signific
bronchodil
respons
observ
even
baselin
measur
although
small
nonsignific
magnitud
consist
anoth
studi
observ
might
impli
higher
bronchomotor
tone
keep
prolong
postvir
nonspecif
hyperrespons
shown
type
wheezer
viral
identif
similar
previous
publish
data
analog
peak
upper
lower
respiratori
tract
symptom
differ
significantli
regard
atopi
find
describ
studi
compar
healthi
subject
mild
asthma
likewis
atop
statu
prove
play
signific
role
feno
prebronchodil
fev
fluctuat
major
strength
studi
steroidna
cohort
use
make
result
robust
easier
interpret
howev
weak
studi
lack
healthi
control
group
ethic
consider
salbutamol
administr
healthi
children
howev
tri
overcom
use
accept
predict
equat
lung
function
test
normal
feno
valu
individu
baselin
measur
compar
adjust
outcom
interest
conclus
studi
clearli
demonstr
inflamm
airway
limit
symptom
significantli
associ
longitudin
manner
throughout
acut
wheez
episod
children
virusinduc
wheez
episod
feno
valu
increas
significantli
first
hour
episod
return
baselin
person
normal
valu
within
day
basi
fet
expect
age
group
fev
seem
appropri
paramet
assess
airflow
limit
bronchodil
respons
baselin
wheez
episod
feno
fev
also
promis
correctli
identifi
monitor
patient
virusinduc
airway
obstruct
acut
phase
wheez
episod
longitudin
assess
timedepend
lung
function
airway
inflamm
paramet
appear
superior
crosssect
analys
time
highlight
need
individu
approach
patient
complex
diseas
asthma
thank
patient
parent
particip
also
thank
andrew
ross
english
edit
prematur
children
week
gestat
congenit
anomali
facial
thorac
mediastin
disord
hospit
respiratori
tract
infect
past
histori
pneumoniatuberculosisinterstiti
lung
diseas
need
mechan
ventil
enrol
exclud
allerg
sensit
patient
test
specif
ige
immunocap
phadia
follow
aeroallergen
dermatophagoid
pteronyssinu
dermatophagoid
farina
cat
dander
dog
epithelium
mix
grass
pollen
cladosporium
speci
aspergillu
speci
alternaria
speci
oliv
cypress
wall
pellitori
pollen
food
allergen
hen
egg
cow
milk
nut
mix
feno
measur
accord
guidelin
niox
mino
specif
correct
feno
measur
singl
breath
sampl
instantli
analyz
subject
inhal
total
lung
capac
noscrub
filter
avoid
contamin
ambient
exhal
perform
exhal
pressur
cm
h
maintain
fix
flow
rate
ml
pressur
necessari
ensur
closur
soft
palat
avoid
contamin
feno
ga
nasopharynx
concentr
high
addit
target
constant
flow
exhal
rate
consist
washout
phase
follow
plateau
gener
consid
plateau
repres
deriv
primarili
lower
respiratori
tract
cloud
pictur
sound
cue
builtin
flowmet
light
top
devic
enough
incent
help
young
children
blow
right
pressur
exhal
first
valid
measur
record
children
eaten
drunk
least
hour
avoid
nitrat
rich
meal
least
hour
measur
direct
given
accord
dietari
recommend
regular
visit
exacerb
visit
arrang
accord
last
meal
snack
spirometri
children
encourag
keep
mouth
mouthpiec
end
expir
avoid
fet
overestim
symptom
symptom
rate
sever
frequenc
follow
nonenev
mildrar
moderatesometim
quit
sever
often
severeveri
often
upper
airway
symptom
diari
card
includ
blockedstuffi
nose
runni
nose
sneezingitchi
nose
itchysorewateri
eye
hoars
voic
sore
throat
lower
airway
symptom
includ
cough
day
cough
night
wheezingnoisi
breath
day
wheezingnoisi
breath
night
coughwheezingnoisi
breath
exercis
upper
respiratori
score
rang
lower
respiratori
score
rang
two
addit
question
answer
ye
difficulti
breathingshort
breath
nighttim
awaken
caus
breath
difficulti
questionnair
aforement
score
system
sensit
enough
correctli
identifi
wheez
episod
nasal
wash
specimen
viral
identif
total
rna
nasopharyng
wash
obtain
use
phenolchloroform
extract
use
ml
sampl
dilut
rnasednasefre
water
extract
ml
total
rna
kept
revers
transcript
perform
round
ml
total
rna
use
superscript
iii
rnase
ml
nasopharyng
wash
ml
cdna
produc
rhinoviru
pcr
perform
cdna
sampl
ad
ml
cdna
ml
master
mix
contain
pcr
buffer
mmoll
mgcl
mmoll
deoxynucleotid
triphosph
dntp
mmoll
primer
gca
ctt
ctg
ttt
ccc
c
cgg
aca
ccc
aaa
gta
g
uml
platinum
taq
total
reaction
volum
ml
agaros
gel
electrophoresi
product
detect
bp
adenoviru
pcr
perform
cdna
sampl
ad
ml
cdna
ml
master
mix
contain
pcr
buffer
mmoll
mgcl
mmoll
dntp
mmoll
primer
gcc
gag
aag
ggc
gtg
cgc
agg
ta
tac
gcc
aac
tcc
gcc
cac
gcg
ct
uml
platinum
taq
total
reaction
volum
ml
agaros
gel
electrophoresi
product
bp
parainfluenza
total
reaction
volum
ml
pcr
product
bp
elig
children
instruct
studi
physician
perform
accept
feno
measur
spirometri
test
perform
lung
function
laboratori
allergi
research
center
univers
athen
children
follow
regularli
everi
week
case
multipl
nonsymptomat
followup
visit
measur
record
week
episod
use
baselin
measur
feno
spirometri
perform
order
instrument
select
save
best
result
test
perform
row
avoid
antiinflammatori
treatmentinduc
bia
episod
uncontrol
salbutamol
monotherapi
per
design
exclud
analysi
wherea
followup
continu
new
elig
episod
occur
washout
period
least
week
analys
across
time
point
interest
perform
gener
estim
equat
examin
associ
feno
fev
valu
symptom
use
gaussian
famili
distribut
unstructur
correl
structur
distribut
variabl
interest
assess
shapirowilk
test
report
p
valu
base
test
compar
signific
level
stata
window
statacorp
colleg
station
tex
ncsspass
kaysvil
utah
softwar
use
statist
calcul
plot
baselin
ppb
day
ppb
p
valu
baselin
vs
day
day
ppb
p
valu
baselin
vs
day
p
valu
day
vs
day
day
ppb
p
valu
baselin
vs
day
p
valu
day
vs
day
p
valu
day
vs
day
valu
present
median
iqr
p
valu
base
wilcoxon
matchedpair
rank
sum
test
comparison
atop
nonatop
subject
p
valu
base
wilcoxon
rank
sum
test
